Neogen Current Ratio 2012-2025 | NEOG

Neogen current ratio from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Neogen Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-08-31 $0.52B $0.15B 3.58
2025-05-31 $0.58B $0.17B 3.32
2025-02-28 $0.55B $0.14B 3.91
2024-11-30 $0.57B $0.15B 3.77
2024-08-31 $0.54B $0.12B 4.41
2024-05-31 $0.59B $0.15B 3.82
2024-02-29 $0.60B $0.16B 3.82
2023-11-30 $0.62B $0.18B 3.54
2023-08-31 $0.58B $0.14B 4.23
2023-05-31 $0.59B $0.15B 4.03
2023-02-28 $0.56B $0.11B 5.18
2022-11-30 $0.64B $0.15B 4.22
2022-08-31 $0.61B $0.07B 9.07
2022-05-31 $0.63B $0.08B 8.05
2022-02-28 $0.61B $0.07B 9.28
2021-11-30 $0.61B $0.06B 9.75
2021-08-31 $0.61B $0.05B 12.00
2021-05-31 $0.59B $0.05B 11.04
2021-02-28 $0.56B $0.05B 12.09
2020-11-30 $0.58B $0.05B 12.97
2020-08-31 $0.56B $0.05B 11.99
2020-05-31 $0.54B $0.05B 11.08
2020-02-29 $0.52B $0.04B 13.16
2019-11-30 $0.50B $0.04B 12.89
2019-08-31 $0.47B $0.04B 11.71
2019-05-31 $0.45B $0.04B 11.75
2019-02-28 $0.42B $0.03B 12.33
2018-11-30 $0.41B $0.04B 10.69
2018-08-31 $0.40B $0.04B 10.10
2018-05-31 $0.38B $0.04B 9.71
2018-02-28 $0.35B $0.04B 9.44
2017-11-30 $0.34B $0.04B 8.96
2017-08-31 $0.31B $0.04B 8.11
2017-05-31 $0.29B $0.04B 8.14
2017-02-28 $0.28B $0.04B 7.97
2016-11-30 $0.29B $0.03B 8.52
2016-08-31 $0.27B $0.03B 8.23
2016-05-31 $0.25B $0.03B 8.68
2016-02-29 $0.26B $0.03B 9.18
2015-11-30 $0.25B $0.03B 8.02
2015-08-31 $0.24B $0.03B 8.75
2015-05-31 $0.23B $0.03B 9.08
2015-02-28 $0.22B $0.03B 8.19
2014-11-30 $0.21B $0.02B 8.53
2014-08-31 $0.20B $0.02B 8.22
2014-05-31 $0.19B $0.03B 7.56
2014-02-28 $0.18B $0.03B 7.17
2013-11-30 $0.18B $0.02B 7.68
2013-08-31 $0.18B $0.02B 7.79
2013-05-31 $0.17B $0.02B 9.51
2013-02-28 $0.16B $0.02B 7.09
2012-11-30 $0.15B $0.02B 8.33
2012-08-31 $0.15B $0.02B 8.05
2012-05-31 $0.14B $0.02B 7.21
2012-02-29 $0.14B $0.02B 7.81
2011-11-30 $0.13B $0.02B 7.08
2011-08-31 $0.12B $0.02B 6.81
2011-05-31 $0.12B $0.02B 6.88
2011-02-28 $0.11B $0.02B 5.57
2010-11-30 $0.11B $0.02B 5.08
2010-08-31 $0.10B $0.02B 4.90
2010-05-31 $0.09B $0.02B 5.05
2010-02-28 $0.09B $0.02B 6.15
2009-11-30 $0.09B $0.02B 6.08
2009-08-31 $0.08B $0.01B 6.55
2009-05-31 $0.07B $0.01B 7.76
2009-02-28 $0.07B $0.01B 6.26
2008-11-30 $0.07B $0.01B 5.82
2008-08-31 $0.07B $0.01B 5.06
2008-05-31 $0.07B $0.01B 5.89
2008-02-29 $0.06B $0.01B 5.16
2007-11-30 $0.06B $0.01B 5.57
2007-08-31 $0.05B $0.01B 5.39
2007-05-31 $0.05B $0.01B 5.09
2007-02-28 $0.05B $0.01B 5.25
2006-11-30 $0.05B $0.01B 4.68
2006-08-31 $0.04B $0.01B 5.00
2006-05-31 $0.04B $0.01B 3.62
2006-02-28 $0.04B $0.01B 4.24
2005-11-30 $0.03B $0.01B 5.18
2005-08-31 $0.03B $0.01B 4.43
2005-05-31 $0.03B $0.01B 4.95
2005-02-28 $0.03B $0.01B 5.69
2004-11-30 $0.03B $0.01B 4.31
2004-08-31 $0.03B $0.01B 4.78
2004-05-31 $0.03B $0.01B 4.65
2004-02-29 $0.03B $0.01B 4.05
2003-11-30 $0.02B $0.01B 4.48
2003-08-31 $0.03B $0.00B 6.25
2003-05-31 $0.03B $0.01B 4.85
2003-02-28 $0.03B $0.00B 6.15
2002-11-30 $0.03B $0.00B 5.76
2002-08-31 $0.02B $0.00B 5.80
2002-05-31 $0.02B $0.00B 5.96
2002-02-28 $0.02B $0.00B 7.10
2001-11-30 $0.02B $0.00B 6.64
2001-08-31 $0.02B $0.00B 6.01
2001-05-31 $0.02B $0.00B 6.47
2001-02-28 $0.02B $0.00B 7.39
2000-11-30 $0.02B $0.00B 6.99
2000-08-31 $0.02B $0.00B 6.28
2000-05-31 $0.02B $0.00B 6.47
2000-02-29 $0.02B $0.00B 9.35
1999-11-30 $0.02B $0.00B 12.94
1999-08-31 $0.02B $0.00B 12.62
1999-05-31 $0.02B $0.00B 10.04
1999-02-28 $0.02B $0.00B 14.18
1998-11-30 $0.02B $0.00B 10.93
1998-08-31 $0.02B $0.00B 11.08
1998-05-31 $0.02B $0.00B 13.28
1998-02-28 $0.02B $0.00B 11.06
1997-11-30 $0.02B $0.00B 11.35
1997-08-31 $0.02B $0.00B 10.86
1997-05-31 $0.02B $0.00B 10.72
1997-02-28 $0.02B $0.00B 11.04
1996-11-30 $0.02B $0.00B 10.79
1996-08-31 $0.01B $0.00B 3.18
1996-05-31 $0.01B $0.00B 3.29
1996-02-29 $0.01B $0.00B 3.32
1995-11-30 $0.01B $0.00B 3.16
1995-08-31 $0.01B $0.00B 3.32
1995-05-31 $0.01B $0.00B 3.53
1995-02-28 $0.01B $0.00B 3.30
1994-11-30 $0.01B $0.00B 3.62
1994-08-31 $0.01B $0.00B 3.77
1994-05-31 $0.01B $0.00B 4.72
1994-02-28 $0.01B $0.00B 4.19
1993-11-30 $0.01B $0.00B 3.96
1993-08-31 $0.01B $0.00B 4.31
1993-05-31 $0.01B $0.00B 4.96
1993-02-28 $0.01B $0.00B 5.01
1992-11-30 $0.01B $0.00B 5.19
1992-08-31 $0.01B $0.00B 6.37
1992-05-31 $0.01B $0.00B 5.61
1992-02-29 $0.01B $0.00B 7.89
1991-11-30 $0.01B $0.00B 7.91
1991-08-31 $0.01B $0.00B 6.21
1991-05-31 $0.01B $0.00B 7.66
1991-02-28 $0.01B $0.00B 7.94
1990-11-30 $0.01B $0.00B 7.64
1990-08-31 $0.01B $0.00B 7.85
1990-05-31 $0.01B $0.00B 9.23
1990-02-28 $0.01B $0.00B 8.60
1989-11-30 $0.01B $0.00B 8.46
1989-08-31 $0.01B $0.00B 4.04
1989-05-31 $0.00B $0.00B 1.53
1988-05-31 $0.00B $0.00B 1.64
1988-02-29 $0.00B $0.00B 1.53
1987-05-31 $0.00B 0.00
1987-02-28 $0.00B $0.00B 1.64
1986-02-28 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.058B $0.895B
Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $214.803B 24.76
EssilorLuxottica (ESLOY) France $151.023B 0.00
Stryker (SYK) United States $138.625B 27.52
Boston Scientific (BSX) United States $133.464B 30.52
Medtronic (MDT) Ireland $126.919B 17.58
Medline (MDLN) United States $56.109B 0.00
Lonza Group Ag (LZAGY) Switzerland $49.167B 0.00
Agilent Technologies (A) United States $41.059B 25.95
ResMed (RMD) United States $38.047B 26.33
GE HealthCare Technologies (GEHC) United States $37.585B 17.98
Koninklijke Philips (PHG) Netherlands $29.051B 18.98
Terumo (TRUMY) Japan $20.817B 23.43
Insulet (PODD) United States $20.154B 62.55
Zimmer Biomet Holdings (ZBH) United States $17.589B 10.97
Smith & Nephew SNATS (SNN) United Kingdom $13.974B 0.00
Baxter (BAX) United States $10.471B 8.45
Sunny Optical Technology (SNPTF) China $9.589B 0.00
Bio-Rad Laboratories (BIO) United States $8.688B 31.24
Demant (WILYY) Denmark $7.372B 0.00
Lantheus Holdings (LNTH) United States $4.338B 13.22
BillionToOne (BLLN) United States $4.335B 0.00
Envista Holdings (NVST) United States $4.060B 23.29
ICU Medical (ICUI) United States $3.829B 24.31
Haemonetics (HAE) United States $3.464B 15.42
Prestige Consumer Healthcare (PBH) United States $3.155B 14.39
Shandong Weigao Medical Polymer (SHWGF) China $3.099B 0.00
QuidelOrtho (QDEL) United States $2.403B 15.45
Perrigo (PRGO) Ireland $2.088B 5.23
AtriCure (ATRC) United States $2.061B 0.00
LeMaitre Vascular (LMAT) United States $1.962B 39.50
Curaleaf Holdings (CURLF) Canada $1.846B 0.00
Green Thumb Industries (GTBIF) United States $1.715B 75.18
Phibro Animal Health (PAHC) United States $1.624B 16.22
Lumexa Imaging Holdings (LMRI) United States $1.459B 0.00
AdaptHealth (AHCO) United States $1.441B 20.86
Kestra Medical Technologies (KMTS) United States $1.341B 0.00
BioLife Solutions (BLFS) United States $1.178B 349.57
Capricor Therapeutics (CAPR) United States $1.099B 0.00
Tilray Brands (TLRY) Canada $1.090B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.944B 0.00
InMode (INMD) Israel $0.888B 10.04
Omeros (OMER) United States $0.866B 0.00
Valneva SE (VALN) France $0.865B 0.00
CeriBell (CBLL) United States $0.847B 0.00
VAREX IMAGING (VREX) United States $0.581B 15.75
Cerus (CERS) United States $0.526B 0.00
Verano Holdings (VRNO) United States $0.494B 0.00
Cresco Labs (CRLBF) United States $0.486B 0.00
Brainsway (BWAY) Israel $0.452B 77.00
Canopy Growth (CGC) Canada $0.450B 0.00
SNDL (SNDL) Canada $0.426B 0.00
Quanterix (QTRX) United States $0.371B 0.00
Evolus (EOLS) United States $0.324B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.309B 0.00
TriSalus Life Sciences (TLSI) United States $0.307B 0.00
Viemed Healthcare (VMD) United States $0.287B 22.85
TerrAscend (TSNDF) Canada $0.244B 0.00
Aurora Cannabis (ACB) Canada $0.240B 141.33
Sanuwave Health (SNWV) United States $0.238B 0.00
High Tide (HITI) Canada $0.220B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Organigram Global (OGI) Canada $0.215B 0.00
Sanara MedTech (SMTI) United States $0.212B 0.00
OraSure Technologies (OSUR) United States $0.197B 0.00
Accendra Health (ACH) United States $0.196B 1.96
Utah Medical Products (UTMD) United States $0.193B 17.02
Vireo Growth (VREOF) United States $0.193B 0.00
Quipt Home Medical (QIPT) United States $0.158B 0.00
Apyx Medical (APYX) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.147B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.147B 0.00
Jushi Holdings (JUSHF) United States $0.117B 0.00
Fonar (FONR) United States $0.116B 16.79
Exagen (XGN) United States $0.109B 0.00
Biote (BTMD) United States $0.109B 4.78
MacroGenics (MGNX) United States $0.108B 0.00
Sharps Technology (STSS) United States $0.067B 0.00
ImmuCell (ICCC) United States $0.060B 25.54
Nephros (NEPH) United States $0.047B 33.69
Cytosorbents (CTSO) United States $0.043B 0.00
Veru (VERU) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Modular Medical (MODD) United States $0.037B 0.00
United-Guardian (UG) United States $0.029B 14.86
Allurion Technologies (ALUR) United States $0.023B 0.00
Jin Medical (ZJYL) China $0.023B 0.00
Bonk (BNKK) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
INLIF (INLF) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Flora Growth (FLGC) United States $0.007B 0.00
Agape ATP (ATPC) $0.005B 0.00
Zynex (ZYXI) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.000B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00